These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4343964)

  • 21. High responsiveness of cytosolic free calcium concentration to angiotensin II in cultured pulmonary arterial myocytes from pulmonary hypertensive rats.
    Li Z; Zhang Q; Zhao S; Wei M; Cong H; Ouda H; Odajima K; Takemura H
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):125-30. PubMed ID: 9344225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium-entry blockade and pressor effect of angiotensin II in normal and nephrectomized rats.
    Iaina A; Goldfarb D; Kapuler S; Serban I; Gavendo S; Eliahou HE
    Isr J Med Sci; 1984 Mar; 20(3):207-10. PubMed ID: 6724865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex effects of antibodies to polypeptide hormones.
    Goodfriend TL; Webster ME; McGuire JS
    J Clin Endocrinol Metab; 1970 May; 30(5):565-72. PubMed ID: 4192201
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic vascular autoregulation amplifies pressor responses to vasoconstrictor agents.
    Metting PJ; Stein PM; Stoos BA; Kostrzewski KA; Britton SL
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R98-105. PubMed ID: 2912228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of radioimmunologic determination of renin activity and the concentration of angiotensin II in the plasma of hypertensive patients].
    Serebrovskaia IuA; Ustinova SE
    Kardiologiia; 1976 Nov; 16(11):70-7. PubMed ID: 1011470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    Clin Invest Med; 1993 Jun; 16(3):177-86. PubMed ID: 8365045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of angiotensin II upon platelet adhesiveness and the thrombelastogram in patients with essential arterial hypertension.
    Uza G; Crîsnic I
    Pathol Eur; 1975; 10(4):327-32. PubMed ID: 1208124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure.
    Jacobi J; Schlaich MP; Delles C; Schobel HP; Schmieder RE
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):418-22. PubMed ID: 10232503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of angiotensin II blood concentrations in hypertensive rats.
    Ballard JR
    Br J Pharmacol; 1972 Nov; 46(3):573P-574P. PubMed ID: 4348185
    [No Abstract]   [Full Text] [Related]  

  • 30. Neurohumoral contributions to chronic angiotensin-induced hypertension.
    Bruner CA; Fink GD
    Am J Physiol; 1986 Jan; 250(1 Pt 2):H52-61. PubMed ID: 2867686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide affects angiotensin II pressor response: possible mechanism of attenuated pressor response during pregnancy and etiology of pregnancy-induced hypertension.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Gynecol Obstet Invest; 2000; 49(2):84-7. PubMed ID: 10671813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma angiotensin-like activity in hypertension.
    Gulati OP; Nanivadekar SA; Chakravarti RN; Sen PK
    J Assoc Physicians India; 1974 Feb; 22(2):139-42. PubMed ID: 4367554
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma-levels of endothelin-1 and angiotensin-II and reactivity of arterial blood pressure to exogenous sympathomimetics and vasoactive peptides in rat model of malignant renal hypertension.
    Mislovicova M; Kettmann V; Moncek F; Drimal J; Drimal D; Doherty AM; Drimal J
    Bratisl Lek Listy; 2000; 101(3):123-9. PubMed ID: 10870254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.
    Simões E Silva AC; Diniz JS; Regueira Filho A; Santos RA
    J Pediatr; 2004 Jul; 145(1):93-8. PubMed ID: 15238914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of angiotensin II on the renal antioxidant activities of borderline hypertensive rats.
    Ha JH; Jin DQ; Shin SM; Moon HG; Lee ES; Park YH
    Kidney Blood Press Res; 2001; 24(3):185-91. PubMed ID: 11528211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats.
    Wright JW; Sullivan MJ; Quirk WS; Batt CM; Harding JW
    J Hypertens Suppl; 1986 Dec; 4(6):S408-11. PubMed ID: 3475426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of vasoactive substances by trypsin--effect of pH differences on the generation.
    Ikeda M; Sakai T; Yuki M; Geji T; Arakawa K
    Jpn Circ J; 1977 Aug; 41(8):871-2. PubMed ID: 20522
    [No Abstract]   [Full Text] [Related]  

  • 39. New vasoconstrictor, bovine peptide B, released during blood coagulation.
    Colman RW; Osbahr AJ; Morris RE
    Nature; 1967 Jul; 215(5098):292-3. PubMed ID: 4293844
    [No Abstract]   [Full Text] [Related]  

  • 40. Endothelin-1 in cerebrospinal fluid in elderly patients with hypertension and dementia.
    Nakajima M; Morimoto S; Takamoto S; Kitano S; Fukuo K; Onishi T; Ogihara T
    Hypertension; 1994 Jul; 24(1):97-100. PubMed ID: 8021015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.